NCT07133087 Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer Survivors
| NCT ID | NCT07133087 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Halic University |
| Condition | Breast Cancer Female |
| Study Type | OBSERVATIONAL |
| Enrollment | 42 participants |
| Start Date | 2025-05-06 |
| Primary Completion | 2025-10-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 42 participants in total. It began in 2025-05-06 with a primary completion date of 2025-10-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Breast cancer is one of the most common types of cancer among women and one of the leading causes of morbidity and mortality. With increasing survival rates, issues such as treatment-related morbidities and consequently upper extremity dysfunction, reduced body awareness, and decreased quality of life are frequently encountered. In the literature, the impact of treatment-related morbidities-particularly on upper extremity functions, body awareness, and quality of life-among women who have survived breast cancer treatment has not been sufficiently investigated. This gap constitutes a significant shortcoming in terms of clinical practices and the post-treatment period. This study aims to examine the effects of breast cancer treatment on upper extremity functions, body awareness, and quality of life in women who have survived breast cancer treatment, in comparison with a healthy control group. The study will be conducted at Yeditepe University Koşuyolu Hospital between May, 2025, and October, 2025. Participants will include women who have survived breast cancer treatment and a healthy control group matched based on criteria such as age and body mass index. In the study, three separate assessments will be conducted for upper extremity functions: the "Quick Disabilities of the Arm, Shoulder, and Hand" (QuickDASH) questionnaire for upper extremity functionality, a hand dynamometer for grip strength, and the Clinometer device for shoulder joint position sense. The "Body Awareness Questionnaire" will be used to assess body awareness, and the "EORTC QLQ-C30" scale will be used for quality of life assessment. The IBM SPSS Statistics software package will be used for data analysis. In statistical analyses, a significance level of p\<0.05 will be considered.
Eligibility Criteria
Inclusion Criteria for breast cancer survivors: * Being a woman * Being between the ages of 25 and 75 * Having been diagnosed with Stage 0-III breast cancer * Having completed primary treatments (surgery, chemotherapy, and/or radiation therapy) no more than 6 months prior to the assessment date * Having received medical clearance from a physician * Having undergone either breast-conserving surgery or mastectomy due to breast cancer * Willingness to participate in the study voluntarily Exclusion Criteria for breast cancer survivors: * Having a history of rehabilitation due to upper extremity, thoracic, or cervical musculoskeletal disorders within 6 months prior to the breast cancer diagnosis * Having a history of neuromuscular dysfunction * Using medications that may affect neuromuscular performance Inclusion criteria for the control group: * Being a woman * Having a body mass index (BMI) within ±3 kg/m² of the breast cancer survivor group * Being within ±5 years of age compared to the breast cancer survivor group * Matching hand dominance with the breast cancer survivor group Exclusion criteria for the control group: * Having a history of neuromuscular dysfunction * Using medications that may affect neuromuscular performance * Having a history of rehabilitation due to upper extremity, thoracic, or cervical musculoskeletal disorders within the last 6 months
Contact & Investigator
Seda Saka, PhD
STUDY DIRECTOR
Haliç University
Frequently Asked Questions
Who can join the NCT07133087 clinical trial?
This trial is open to female participants only, aged 25 Years or older, up to 75 Years, studying Breast Cancer Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07133087 currently recruiting?
Yes, NCT07133087 is actively recruiting participants. Contact the research team at sedasaka@halic.edu.tr for enrollment information.
Where is the NCT07133087 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye), Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07133087 clinical trial?
NCT07133087 is sponsored by Halic University. The principal investigator is Seda Saka, PhD at Haliç University. The trial plans to enroll 42 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.